Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma.

[1]  W. Jonat,et al.  Transforming Growth Factor β2 (TGF-β2) Levels in Plasma of Patients with Metastatic Breast Cancer Treated with Tamoxifen , 1995 .

[2]  M. Anscher,et al.  Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor , 1995, Annals of surgery.

[3]  A. Melman,et al.  Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer , 1995, Nature Medicine.

[4]  M. Steiner,et al.  Expression of transforming growth factor-beta 1 in prostate cancer. , 1994, Endocrinology.

[5]  J. Richie,et al.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.

[6]  J. Gordon,et al.  Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells. , 1993, Cancer research.

[7]  J. Richie,et al.  Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. , 1993, Journal of the National Cancer Institute.

[8]  D. Danielpour.  Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. , 1993, Journal of immunological methods.

[9]  R. Macchia,et al.  Growth factors in urologic tissues: detection, characterization, and clinical applications. , 1992, Urology.

[10]  R. Maciunas,et al.  TGFβ1 and TGFβ2 are potential growth regulators for low‐grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesis , 1991 .

[11]  C. Knabbe,et al.  Endocrine dependent tumors , 1991 .

[12]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[13]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[14]  M. Nakajima,et al.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Moses,et al.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane , 1990, The Journal of cell biology.

[16]  H. Moses,et al.  The cell biology of transforming growth factor β , 1990 .

[17]  N. Bouck.  Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. , 1990, Cancer cells.

[18]  H. Moses,et al.  Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.

[19]  F. Hahn,et al.  Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells. , 1989, Carcinogenesis.

[20]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[21]  M. Sporn,et al.  Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture , 1989 .

[22]  H. Koeppen,et al.  Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. , 1988, Cancer research.

[23]  M. Tsao,et al.  Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. , 1988, Cancer research.

[24]  M. O’Connor-McCourt,et al.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.

[25]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[26]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[27]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Lawrence,et al.  Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. , 1986, Biochemical and biophysical research communications.

[29]  H. Moses,et al.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. , 1984, Science.

[30]  S. Kumar,et al.  Tumour angiogenesis factor in urological cancers. , 1984, British journal of urology.

[31]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[32]  W Lutzeyer,et al.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.

[33]  M. Sporn,et al.  Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Grace,et al.  The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis , 1995, Nature Medicine.

[35]  M. Sporn,et al.  Transforming Growth Factor-β1 Circulates in Normal Human Plasma and is Unchanged in Advanced Metastatic Breast Cancer , 1995 .

[36]  P. Scardino,et al.  Transforming growth factor β1 as a biomarker for prostate cancer , 1992 .

[37]  M. Sporn,et al.  Roles for transforming growth factors-beta in the genesis, prevention, and treatment of breast cancer. , 1992, Cancer treatment and research.

[38]  G. Wilding.  Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta. , 1991, Cancer surveys.

[39]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[40]  J. Kehrl.  Transforming growth factor-beta: an important mediator of immunoregulation. , 1991, International journal of cell cloning.

[41]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[42]  M. Sporn,et al.  Recombinant TGF-β1 is Synthesized as a Two-Component Latent Complex that Shares Some Structural Features with the Native Platelet Latent TGF-β1 Complex , 1989 .

[43]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[44]  F. Freiha,et al.  Superficial bladder cancer: the primacy of grade in the development of invasive disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  M. Sporn,et al.  Growth factors and transformation. , 1986, Cancer surveys.

[46]  M. Knowles,et al.  Integrated pest management. , 1976, Environmental health perspectives.